Literature DB >> 8662126

Severity stratification and outcome prediction for multisystem organ failure and dysfunction.

J E Zimmerman1, W A Knaus, X Sun, D P Wagner.   

Abstract

Multiple organ system failure or dysfunction (MOSF/MODS) remains a major cause of morbidity and mortality in hospitalized adults. Among intensive care unit (ICU) patients the extent of physiologic derangement, the type of associated disease or injury, increasing age, and life-threatening comorbid conditions are the major determinants of risk for developing MOSF and for survival during the 1980s. Hospital mortality for patients with a single organ system failure (OSF) lasting more than 1 day approached 40%; and for those with two OSFs hospital mortality increased to 60%. These outcomes did not change over the decade. For patients with three or more OSFs persisting after 3 days of OSF, however, data suggest that between 1982 and 1990 the mortality has been reduced from 98% to 84% (p = 0.0003). Because of variations in the types and combinations of OSFs, associated disease, and extent of physiologic derangement, it is difficult to interpret variations in mortality among patients with one or more OSFs defined using categorical criteria. For this and other reasons, outcome prediction based on a comprehensive assessment of patient risk factors is a more sensitive, specific, useful approach to quantifying MODS than a simple count of the number and duration of OSFs. Because repeated assessment of risk factors during subsequent ICU days reflects complications and response to therapy, daily outcome predictions are even more precise than estimates at ICU admission. The ability to more accurately predict survival from MODS/MOSF can improve our ability to test new therapies, evaluate how outcome has changed over time, and assess the efficacy of supportive therapy for individuals.

Entities:  

Mesh:

Year:  1996        PMID: 8662126     DOI: 10.1007/s002689900063

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  10 in total

1.  Generation and evaluation of intraoperative inferences for automated health care briefings on patient status after bypass surgery.

Authors:  D A Jordan; K R McKeown; K J Concepcion; S K Feiner; V Hatzivassiloglou
Journal:  J Am Med Inform Assoc       Date:  2001 May-Jun       Impact factor: 4.497

2.  Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B.

Authors:  Hui-Guo Ding; Jing Shan; Bin Zhang; Hong-Bo Ma; Li Zhou; Rui Jin; Yu-Fen Tan; Li-Xiang He
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

3.  A 9-year, single-institution, retrospective review of death rate and prognostic factors in adult respiratory distress syndrome.

Authors:  T R Rocco; S E Reinert; W Cioffi; D Harrington; G Buczko; H H Simms
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

4.  Epidermal growth factor reduces multiorgan failure induced by thioacetamide.

Authors:  M E Caballero; J Berlanga; D Ramirez; P Lopez-Saura; R Gozalez; D N Floyd; T Marchbank; R J Playford
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

5.  Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage.

Authors:  Jorge Berlanga; Pedro Prats; Diadelis Remirez; Ricardo Gonzalez; Pedro Lopez-Saura; Jorge Aguiar; Miriam Ojeda; Joseph J Boyle; Anthony J Fitzgerald; Raymond J Playford
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Multimedia abstract generation of intensive care data: the automation of clinical processes through AI methodologies.

Authors:  Desmond Jordan; Sydney E Rose
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

7.  Evaluation of effect of hybrid bioartificial liver using end-stage liver disease model.

Authors:  Qing Liu; Zhong-Ping Duan; Chun Huang; Chun-Hui Zhao
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

8.  Predicting multiple organ failure in patients with severe trauma.

Authors:  Zeljko Lausevic; Mirjana Lausevic; Jasna Trbojevic-Stankovic; Slobodan Krstic; Biljana Stojimirovic
Journal:  Can J Surg       Date:  2008-04       Impact factor: 2.089

9.  The outcomes of using colistin for treating multidrug resistant Acinetobacter species bloodstream infections.

Authors:  Seung-Kwan Lim; Sang-Oh Lee; Seong-Ho Choi; Jae-Phil Choi; Sung-Han Kim; Jin-Yong Jeong; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim
Journal:  J Korean Med Sci       Date:  2011-02-25       Impact factor: 2.153

10.  Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.

Authors:  Aline C Q Leão; Paulo R Menezes; Maura S Oliveira; Anna S Levin
Journal:  BMC Infect Dis       Date:  2016-08-09       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.